Derms on Drugs

Auteur(s): Scholars in Medicine
Écouter gratuitement

  • Résumé

  • Derms on Drugs is where cutting-edge dermatology meets mediocre comedy. Each week three dermatologists – Matt Zirwas, Laura Ferris and Tim Patton – discuss, debate, and dissect the hottest topics in dermatology. It's everything you need to know to be on the cutting-edge of dermatology and it’ll be the most fun you’ve ever had while actually learning something useful. Derms on Drugs is produced by Scholars in Medicine, an online educational platform (scholarsinmedicine.com) exclusively for healthcare professionals of all levels of experience and education.
    Scholars in Medicine
    Voir plus Voir moins
Hygiene & Healthy Living Troubles et maladies
Voir plus Voir moins
Épisodes
  • The Derms on Drugs Take on Big Questions

    The Derms on Drugs Take on Big Questions
    Feb 28 2025

    -Big BCCs – Debulk First or Chemo First?;

    -Do Covid or the Covid Vaccine Affect the Risk of Getting a Bullous Disease?

    -Does Drinking Drive Melasma?

    But of course that’s not all: Should we be treating Strep to help our psoriasis patients get better faster? What Biologics are new on the horizon for treating linear morphea? And just how well does oral roflumilast work for psoriasis?

    Join us this week for more dermatology takes that you won’t get anywhere else!


    1. Surgical Debulking Modifies Notch Signaling and May Improve Vismodegib Effectiveness for Locally Advanced Basal Cell Carcinoma

    https://pubmed.ncbi.nlm.nih.gov/39086988/


    2. COVID-19 infection is associated with an elevated risk for autoimmune blistering diseases while COVID-19 vaccination decreases the risk: A large-scale population-based cohort study of 112 million individuals

    https://pubmed.ncbi.nlm.nih.gov/39521140/


    3. Diet and Living Environment as Novel Etiological Factors for Melasma: The Results Form a Retrospective Case-Control Study of 150 Chinese Patients

    https://pubmed.ncbi.nlm.nih.gov/39931907/


    4. The impact of antibiotic therapy in psoriasis patients with active streptococcal infection: A prospective study

    https://pubmed.ncbi.nlm.nih.gov/39895559/


    5. Use of biologic drug in the treatment of localized scleroderma and systemic sclerosis in children: A scoping review

    https://pubmed.ncbi.nlm.nih.gov/39938346/


    6. Oral roflumilast for psoriasis: a real-world 24-week prospective cohort study

    https://pubmed.ncbi.nlm.nih.gov/39933751/


    7. A randomized, controlled pilot study of oral roflumilast compared with intramuscular methotrexate for plaque and scalp psoriasis

    https://pubmed.ncbi.nlm.nih.gov/38266682/


    8. Roflumilast and cognition enhancement: A translational perspective

    https://pubmed.ncbi.nlm.nih.gov/39591666/


    9. Acute treatment with the PDE4 inhibitor roflumilast improves verbal word memory in healthy old individuals: a double-blind placebo-controlled study

    https://pubmed.ncbi.nlm.nih.gov/30776650/


    10. Acute administration of roflumilast enhances immediate recall of verbal word memory in healthy young adults

    https://pubmed.ncbi.nlm.nih.gov/29241652/
    Voir plus Voir moins
    34 min
  • Psoriasiform Dermatitis and Idiopathic Erythroderma - The Derms on Drugs Clear Up Some Murky Topics

    Psoriasiform Dermatitis and Idiopathic Erythroderma - The Derms on Drugs Clear Up Some Murky Topics
    Feb 21 2025

    Psoriasiform Dermatitis - the Derms on Drugs take on your worst nightmare when it comes to path reports. Dermatitis? Psoriasis? Both? Neither? We'll get into the weeds with Amber Atwater, who looked at what the final diagnoses ended up being in hundreds of patients with psoriasiform dermatitis that gives us some clues on how to approach these patients. We also review the latest work on idiopathic erythroderma - not so idiopathic anymore, thanks to the hard work and genius of Shawn Kwatra at the University of Maryland. And, stick around to the end for some hard hitting trivia on the American Contact Dermatitis Society's last 25 years of Allergens of the Year.

    Join us for another episode of Derms on Drugs, brought to you by Scholars in Medicine.

    1. Targeted dual biologic therapy for erythroderma of unknown etiology guided by high-parameter peripheral blood immunophenotyping
    https://pubmed.ncbi.nlm.nih.gov/39809837/

    2. Molecular Structure and Function of Janus Kinases: Implications for the Development of Inhibitors
    https://pubmed.ncbi.nlm.nih.gov/32083640/

    3. Final clinical diagnosis in cases of histopathologic psoriasiform dermatitis: retrospective cross-sectional analysis of a Southeastern United States population, 2004-2017
    https://pubmed.ncbi.nlm.nih.gov/39792248/

    4. Epidermal spongiotic Langerhans cell collections, but not eosinophils, are a clue to the diagnosis of allergic contact dermatitis: A series of 170 clinically- and patch test-confirmed cases
    https://pubmed.ncbi.nlm.nih.gov/39709083/

    5. The 2023 Annual Report of DataDerm: The database of the American Academy of Dermatology
    https://pubmed.ncbi.nlm.nih.gov/38936667/

    6. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis
    https://pubmed.ncbi.nlm.nih.gov/24290431/

    7. The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statement
    https://pubmed.ncbi.nlm.nih.gov/34365875/

    8. Toluene-2,5-Diamine Sulfate: Allergen of the Year 2025
    https://pubmed.ncbi.nlm.nih.gov/39862176/
    Voir plus Voir moins
    43 min
  • Derms on Drugs Debunks the "Benzene in Benzoyl Peroxide" Story

    Derms on Drugs Debunks the "Benzene in Benzoyl Peroxide" Story
    Feb 14 2025
    We all kind of freaked out when the news broke that benzene had been detected in benzoyl peroxide. I mean, makes sense, right -benzene even sounds like benzoyl - how did nobody think of this before! And the lab that detected it got Zantac pulled from the market and it was even discussed at Fall Clinical..."There is no safe amount of exposure to benzene..." The final straw was when an article dropped in JID -JID for goodness sake - about the problem.Not so fast. Our trio did a deep dive and there is WAY more to this story than meets the eye. Join us as we get into the nitty grittywith John Barbieri (from Harvard!) about his published research on the topic along with the well­ known Australian cosmetic chemist, Michelle Wong, PhD (aka "Lab Muffin").Derms on Drugs is produced by Scholars in Medicine.John Barieri John Barbieri, MD, MBA is an Assistant Professor at Harvard Medical School and the Director of the Advanced Acne Therapeutics Clinic at the Brigham and Women’s Hospital. He is an associate editor at JAMA Dermatology and is also the co-chair of the American Academy of Dermatology Acne Guidelines Work Group. His research is focused on conducting innovative clinical trials, health economic, and epidemiology studies to identify the best approaches to care for patients with acne. He also focuses on exploring the role of patient-reported outcomes to ensure we are capturing the patient’s voice and perspective on their care. Dr. Barbieri has received consulting fees from Honeydew Care.Michelle WongMichelle Wong is a science educator and chemistry PhD. In 2011 she started the website Lab Muffin Beauty Science, where she explains the science behind beauty products for a general audience. She has since expanded to YouTube, Instagram and TikTok, and is known for her work debunking myths. Her book The Science of Beauty was released in June 2024, and she is the cofounder of BeautySciComm. Through her science communication work, Michelle has worked with many brands on campaigns, and delivered invited talks at international conferences. Her work has been featured in Wired, The New York Times, ABC News, and Chemistry & Engineering News.Social media handles:YouTube, IG, Threads, TikTok: @labmuffinbeautyscienceBluesky: labmuffin.comWebsite: labmuffin.comSubstack: labmuffin.substack.comResources:1. Evaluation of Benzene Presence and Formation in Benzoyl Peroxide Drug Products PubMed: https://pubmed.ncbi.nlm.nih.gov/39384016/Full Text Link: www.jidonline.org/action/showPdf? 2. No evidence for an association between benzoyl peroxide use and increased blood benzene levels in the National Health and Nutrition Examination SurveyPubMed: https://pubmed.ncbi.nlm.nih.gov/38950699/Full Text: https://www.jaad.org/article/S0190-9622(24)00980-0/fulltext 3. Benzoyl peroxide for acne treatment is not associated with an increased risk of malignancy: A retrospective cohort studyPubMed: https://pubmed.ncbi.nlm.nih.gov/39002561/Full Text: https://www.jaad.org/article/S0190-9622(24)01051-X/fulltext 4: Benzene in your products, Part 2: The story of Valisure. Lab Muffin Beauty Science. https://labmuffin.com/benzene-in-your-products-part-2-the-story-of-valisure/5: Shelf-stable formulations of benzoyl peroxide and methods of producing same https://patents.google.com/patent/WO2023177625A1/en6. A Legal Shakedown Exposed: How Valisure tried to cash in on its dubious claims about cancer. https://www.wsj.com/articles/valisure-cancer-claims-zantac-dry-shampoo-david-Iight-11675806424
    Voir plus Voir moins
    35 min

Ce que les auditeurs disent de Derms on Drugs

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.